Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity-Reference-Cited by-同舟云学术

Faecal microbiota transplantation: A life-saving therapy challenged by commercial claims for exclusivity

Published:2020-07 Issue: Volume:24 Page:100436
ISSN:2589-5370
Container-title:EClinicalMedicine
language:en
Short-container-title:EClinicalMedicine

Author:

Hvas Christian Lodberg^ORCID,Baunwall Simon Mark Dahl,Erikstrup Christian

Funder

Innovationsfonden

Publisher

Elsevier BV

Subject

General Medicine

Reference10 articles.

1. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications;Allegretti;Lancet,2019

2. Incidence of bloodstream infections, length of hospital stay, and survival in patients with recurrent Clostridioides difficile infection treated with fecal microbiota transplantation or antibiotics: a prospective cohort study;Ianiro;Ann Intern Med,2019

3. Guide to the quality and safety of tissues and cells for human application,2019

4. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice;Cammarota;Gut,2019

5. Results from the first english stool bank using faecal microbiota transplant as a medicinal product for the treatment of Clostridioides difficile infection;McCune;EClin Med,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Gut Microbiota on Mental Health;Nutritional Neurosciences;2024

2. Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options;Microorganisms;2022-03-07

3. Fecal microbiota transfer: Basic and clinical aspects, current applications, and future perspectives;Human-Gut Microbiome;2022

4. The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey;The Lancet Regional Health - Europe;2021-10